Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Water Pollutants, Chemical | 4 | 2014 | 164 | 0.950 |
Why?
|
| Nanoparticles | 4 | 2014 | 318 | 0.820 |
Why?
|
| Artemia | 4 | 2014 | 16 | 0.740 |
Why?
|
| Zinc Oxide | 2 | 2014 | 16 | 0.590 |
Why?
|
| Nigella sativa | 2 | 2005 | 2 | 0.490 |
Why?
|
| Goldfish | 1 | 2014 | 18 | 0.490 |
Why?
|
| Copper | 1 | 2014 | 105 | 0.450 |
Why?
|
| Titanium | 1 | 2012 | 36 | 0.410 |
Why?
|
| Cadmium | 2 | 2011 | 58 | 0.380 |
Why?
|
| Toluene | 2 | 2007 | 10 | 0.340 |
Why?
|
| Breast Neoplasms | 3 | 2005 | 1502 | 0.320 |
Why?
|
| Benzothiazoles | 2 | 2007 | 21 | 0.300 |
Why?
|
| Hepatoblastoma | 1 | 2007 | 3 | 0.290 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2014 | 1039 | 0.280 |
Why?
|
| Hepatocytes | 1 | 2007 | 75 | 0.280 |
Why?
|
| Energy Metabolism | 1 | 2007 | 168 | 0.260 |
Why?
|
| DNA Repair | 1 | 2007 | 188 | 0.260 |
Why?
|
| Malondialdehyde | 3 | 2014 | 41 | 0.260 |
Why?
|
| Fibroblasts | 1 | 2007 | 272 | 0.250 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 803 | 0.250 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 213 | 0.250 |
Why?
|
| Arsenic | 1 | 2007 | 144 | 0.250 |
Why?
|
| Plant Extracts | 2 | 2005 | 286 | 0.230 |
Why?
|
| Diacetyl | 1 | 2003 | 2 | 0.220 |
Why?
|
| Salmonella typhimurium | 1 | 2003 | 40 | 0.220 |
Why?
|
| Pesticides | 1 | 2003 | 52 | 0.210 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 358 | 0.210 |
Why?
|
| Hot Temperature | 1 | 2003 | 128 | 0.210 |
Why?
|
| Staphylococcus aureus | 1 | 2003 | 75 | 0.210 |
Why?
|
| Soil Pollutants | 1 | 2003 | 87 | 0.200 |
Why?
|
| Cell Survival | 4 | 2007 | 864 | 0.200 |
Why?
|
| Oxidative Stress | 5 | 2014 | 938 | 0.190 |
Why?
|
| Environmental Exposure | 1 | 2003 | 216 | 0.190 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2018 | 19 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 136 | 0.150 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 169 | 0.140 |
Why?
|
| Bioprosthesis | 2 | 2005 | 5 | 0.130 |
Why?
|
| Heart Valve Prosthesis | 2 | 2005 | 18 | 0.130 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2005 | 19 | 0.130 |
Why?
|
| Animals | 9 | 2014 | 15081 | 0.130 |
Why?
|
| Lethal Dose 50 | 2 | 2007 | 30 | 0.130 |
Why?
|
| Lipid Peroxidation | 2 | 2012 | 140 | 0.130 |
Why?
|
| Particle Size | 2 | 2013 | 215 | 0.130 |
Why?
|
| Cytoprotection | 2 | 2007 | 36 | 0.120 |
Why?
|
| Food Chain | 1 | 2014 | 16 | 0.120 |
Why?
|
| Liver | 2 | 2011 | 479 | 0.120 |
Why?
|
| Aluminum Oxide | 1 | 2013 | 9 | 0.120 |
Why?
|
| Tissue Distribution | 1 | 2014 | 207 | 0.120 |
Why?
|
| Hydrogen Peroxide | 2 | 2005 | 190 | 0.110 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 2231 | 0.110 |
Why?
|
| Chordae Tendineae | 1 | 2011 | 1 | 0.100 |
Why?
|
| Rheumatic Heart Disease | 1 | 2011 | 5 | 0.100 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2011 | 13 | 0.100 |
Why?
|
| Mitral Valve | 1 | 2011 | 19 | 0.100 |
Why?
|
| Cadmium Compounds | 1 | 2011 | 7 | 0.100 |
Why?
|
| Zinc | 1 | 2012 | 128 | 0.100 |
Why?
|
| Myocardial Contraction | 1 | 2011 | 48 | 0.100 |
Why?
|
| Selenium Compounds | 1 | 2011 | 11 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2011 | 48 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2007 | 1518 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2014 | 454 | 0.090 |
Why?
|
| Kidney | 1 | 2011 | 337 | 0.080 |
Why?
|
| Aortic Valve | 2 | 2005 | 23 | 0.080 |
Why?
|
| Rats, Wistar | 2 | 2007 | 233 | 0.080 |
Why?
|
| Metal Nanoparticles | 1 | 2011 | 183 | 0.080 |
Why?
|
| Rats | 5 | 2011 | 3483 | 0.080 |
Why?
|
| Humans | 9 | 2018 | 37093 | 0.080 |
Why?
|
| Cell Size | 1 | 2007 | 44 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2011 | 1369 | 0.070 |
Why?
|
| Water | 2 | 2006 | 296 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2007 | 98 | 0.070 |
Why?
|
| Mississippi | 2 | 2006 | 122 | 0.070 |
Why?
|
| Water Supply | 1 | 2006 | 57 | 0.070 |
Why?
|
| Rivers | 1 | 2006 | 44 | 0.070 |
Why?
|
| Water Microbiology | 1 | 2006 | 76 | 0.070 |
Why?
|
| Reference Values | 2 | 2003 | 212 | 0.070 |
Why?
|
| Temperature | 2 | 2006 | 286 | 0.070 |
Why?
|
| Heart Valve Diseases | 1 | 2005 | 10 | 0.070 |
Why?
|
| Androstenedione | 2 | 2003 | 17 | 0.070 |
Why?
|
| Dihydrotestosterone | 2 | 2003 | 29 | 0.070 |
Why?
|
| Solvents | 1 | 2005 | 99 | 0.070 |
Why?
|
| Cell Line | 2 | 2007 | 1354 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2007 | 213 | 0.060 |
Why?
|
| DNA Damage | 1 | 2007 | 352 | 0.060 |
Why?
|
| Testosterone | 2 | 2003 | 193 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 190 | 0.060 |
Why?
|
| Ethanol | 1 | 2005 | 192 | 0.060 |
Why?
|
| Bacteria | 1 | 2006 | 255 | 0.060 |
Why?
|
| Adenosarcoma | 1 | 2003 | 1 | 0.060 |
Why?
|
| Renal Artery | 1 | 2003 | 7 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 66 | 0.050 |
Why?
|
| Seeds | 1 | 2003 | 35 | 0.050 |
Why?
|
| Larva | 2 | 2013 | 124 | 0.050 |
Why?
|
| Cell Membrane Permeability | 1 | 2003 | 52 | 0.050 |
Why?
|
| Crops, Agricultural | 1 | 2003 | 31 | 0.050 |
Why?
|
| Food Contamination | 1 | 2003 | 55 | 0.050 |
Why?
|
| Androgens | 1 | 2003 | 89 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2003 | 81 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 307 | 0.050 |
Why?
|
| Cadmium Chloride | 1 | 2002 | 13 | 0.050 |
Why?
|
| Aorta | 1 | 2003 | 167 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 502 | 0.050 |
Why?
|
| Thiazoles | 1 | 2002 | 74 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1015 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 562 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2007 | 1198 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 182 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2002 | 110 | 0.050 |
Why?
|
| Oxides | 1 | 2002 | 89 | 0.050 |
Why?
|
| Myocardium | 1 | 2002 | 235 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2003 | 935 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2003 | 1067 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2018 | 62 | 0.040 |
Why?
|
| Female | 4 | 2005 | 20969 | 0.040 |
Why?
|
| Cytokines | 1 | 2002 | 602 | 0.040 |
Why?
|
| Male | 5 | 2011 | 20025 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2011 | 1618 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2018 | 326 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 974 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2018 | 928 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2005 | 91 | 0.030 |
Why?
|
| Risk Factors | 1 | 2003 | 3562 | 0.030 |
Why?
|
| Ecotoxicology | 1 | 2013 | 9 | 0.030 |
Why?
|
| X-Ray Diffraction | 1 | 2013 | 57 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2013 | 68 | 0.030 |
Why?
|
| Seawater | 1 | 2013 | 45 | 0.030 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2011 | 20 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2011 | 98 | 0.020 |
Why?
|
| Apoptosis | 1 | 2018 | 1398 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2012 | 753 | 0.020 |
Why?
|
| Adult | 1 | 2003 | 11712 | 0.020 |
Why?
|
| Filtration | 1 | 2006 | 14 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 2006 | 51 | 0.020 |
Why?
|
| Quality Control | 1 | 2006 | 36 | 0.020 |
Why?
|
| Recreation | 1 | 2006 | 32 | 0.020 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2005 | 3 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2005 | 24 | 0.020 |
Why?
|
| Reoperation | 1 | 2005 | 24 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2006 | 364 | 0.020 |
Why?
|
| Oxygen | 1 | 2006 | 207 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 43 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 2006 | 192 | 0.020 |
Why?
|
| Echocardiography | 1 | 2005 | 144 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2005 | 325 | 0.020 |
Why?
|
| Aged | 2 | 2005 | 6741 | 0.010 |
Why?
|
| Drug Implants | 1 | 2003 | 21 | 0.010 |
Why?
|
| Calcium Phosphates | 1 | 2003 | 13 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 35 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 4268 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2005 | 1378 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2002 | 153 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2003 | 202 | 0.010 |
Why?
|
| Arsenicals | 1 | 2002 | 85 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 455 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 356 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 2379 | 0.010 |
Why?
|
| Middle Aged | 1 | 2005 | 10129 | 0.010 |
Why?
|